Αρχική
Τύποι καρκίνου
Θεραπείες
Υποστήριξη
Νέα
Κέντρα και ογκολόγοι
Αναζήτηση
Τετάρτη, Νοέμβριος 11, 2026
Ogkologos.com
Αρχική
Τύποι καρκίνου
Θεραπείες
Υποστήριξη
Νέα
Κέντρα και ογκολόγοι
Αρχική
Δημιουργοί
Δημοσιεύσεις από Ogkologos
Ogkologos
4397 ΔΗΜΟΣΙΕΥΣΕΙΣ
0 ΣΧΟΛΙΑ
Drug Combination Shows Promise for Rhabdomyosarcoma, but Can It Get to...
Ogkologos
-
9 Δεκεμβρίου, 2022
0
FDA Approves Olutasidenib for Relapsed or Refractory Acute Myeloid Leukaemia with...
Ogkologos
-
9 Δεκεμβρίου, 2022
0
Cancer in My Community: Reducing Tobacco Use in Tunisia
Ogkologos
-
8 Δεκεμβρίου, 2022
0
The 10-year cancer plan: is improving cancer survival still a priority...
Ogkologos
-
8 Δεκεμβρίου, 2022
0
Research with Integrity – the madness of short methods
Ogkologos
-
7 Δεκεμβρίου, 2022
0
20 years of Cancer Research UK: Celebrating our research nurses
Ogkologos
-
7 Δεκεμβρίου, 2022
0
Tucatinib in Combination with Trastuzumab and Capecitabine Provides Survival Benefits and...
Ogkologos
-
7 Δεκεμβρίου, 2022
0
Why the Fear of Cancer Recurrence Is Often Misunderstood and How...
Ogkologos
-
6 Δεκεμβρίου, 2022
0
Two-Step Approach Might Be An Alternative to Standard Three-Step Approach of...
Ogkologos
-
6 Δεκεμβρίου, 2022
0
Utility of Prospective ctDNA Surveillance in Early TNBC and the Activity...
Ogkologos
-
5 Δεκεμβρίου, 2022
0
1
...
160
161
162
...
440
Σελίδα 161 από 440
MOST POPULAR
Neoadjuvant Treatment with Dual Immune Checkpoint Inhibitors Plus Chemotherapy Produces Numerically...
23 Μαρτίου, 2023
Regular Exercise May Help Guard Breast Cancer Patients From Chemo Brain
20 Αυγούστου, 2021
Pan-FGFR Tyrosine Kinase Inhibitor Treatment Is Less Effective in Patients with...
2 Μαρτίου, 2021
Teacher’s Mental Health Check-In Board Goes Viral For The ‘Beautiful’ Standard...
11 Απριλίου, 2019
Φόρτωση περισσοτέρων
HOT NEWS
Progress in Treating Liver Cancer and Biliary Tract Cancer with Immunotherapy:...
Patient Guide in Bladder Cancer Now Available Also in Italian
Do Black Lives Matter Less Than Those of Cancer Survivors?
Lazertinib Demonstrates Significant Efficacy Improvement Compared with Gefitinib in the First-Line...
Ελληνικά
English (UK)